How dying cells alert the immune system to danger

Nature Reviews Immunology

Volumn 8, Issue 4, 2008, Pages 279-289

  Kono, Hajime ^a   Rock, Kenneth L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; CATHELICIDIN; DEFENSIN; DOUBLE STRANDED DNA; GALECTIN; HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; MYOSIN HEAVY CHAIN; PROTEIN S 100; T LYMPHOCYTE RECEPTOR; THIOREDOXIN; TOLL LIKE RECEPTOR 9; URIC ACID;

ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CANCER CELL; CD4 CD8 RATIO; CD8+ T LYMPHOCYTE; CELL DEATH; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREACTIVITY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL DEATH; HUMANS; INFECTION; LYMPHOCYTE ACTIVATION;

EID: 41149118513     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2215     Document Type: Review

References (123)

1. Dresser, D. W. Effectiveness of lipid and lipidophilic substances as adjuvants. Nature 191, 1169-1171 (1961).
2. Dresser, D. W. Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen. Immunology 5, 378-388 (1962).
3. Janeway, C. A. Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54 (Pt 1), 1-13 (1989).
4. Takeda, K., Kaisho, T. & Akira, S. Toll-like receptors. Annu. Rev. Immunol. 21, 335-376 (2003).
5. Meylan, E., Tschopp, J. & Karin, M. Intracellular pattern recognition receptors in the host response. Nature 442, 39-44 (2006).
6. Kawai, T. & Akira, S. Antiviral signaling through pattern recognition receptors. J. Biochem. (Tokyo) 141, 137-145 (2007).
7. Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045 (1994). This paper introduces the danger model and describes the hypothesis that the recognition of tissue damage is crucial for the activation of antigen-presenting cells and adaptive immune responses.
8. Seong, S. Y. & Matzinger, P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nature Rev. Immunol. 4, 469-478 (2004).
9. Rock, K. L., Hearn, A., Chen, C. J. & Shi, Y. Natural endogenous adjuvants. Springer Semin. Immunopathol. 26, 231-246 (2005).
10. Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: endogenous activators of dendritic cells. Nature Med. 5, 1249-1255 (1999).
11. Shi, Y., Zheng, W. & Rock, K. L. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc. Natl Acad. Sci. USA 97, 14590-14595 (2000). References 10 and 11 identified the existence of endogenous molecules (danger signals) that function as adjuvants to promote acquired immunity.
12. Shi, Y. & Rock, K. L. Cell death releases endogenous adjuvants that selectively enhance immune surveillance of particulate antigens. Eur. J. Immunol. 32, 155-162 (2002).
13. Mathis, D., Vence, L. & Benoist, C. β-cell death during progression to diabetes. Nature 414, 792-798 (2001).
14. Turley, S., Poirot, L., Hattori, M., Benoist, C. & Mathis, D. Physiological β-cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J. Exp. Med. 198, 1527-1537 (2003).
15. Like, A. A. & Rossini, A. A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193, 415-417 (1976).
16. Damico, F. M., Kiss, S. & Young, L. H. Sympathetic ophthalmia. Semin. Ophthalmol. 20, 191-197 (2005).
17. Dressler, W. A post-myocardial infarction syndrome; preliminary report of a complication resembling idiopathic, recurrent, benign pericarditis. J. Am. Med. Assoc. 160, 1379-1383 (1956).
18. Nowak, A. K. et al. Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells. J. Immunol. 170, 4905-4913 (2003).
19. Kouwenhoven, E. A., de Bruin, R. W., Bajema, I. M., Marquet, R. L. & Ijzermans, J. N. Cold ischemia augments allogeneic-mediated injury in rat kidney allografts. Kidney Int. 59, 1142-1148 (2001).
20. Shi, Y., Galusha, S. A. & Rock, K. L. Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model. J. Immunol. 176, 3905-3908 (2006).
21. Hu, D. E., Moore, A. M., Thomsen, L. L. & Brindle, K. M. Uric acid promotes tumor immune rejection. Cancer Res. 64, 5059-5062 (2004).
22. Udono, H. & Srivastava, P. K. Heat shock protein 70-associated peptides elicit specific cancer immunity. J. Exp. Med. 178, 1391-1396 (1993).
23. Feng, H., Zeng, Y., Graner, M. W., Likhacheva, A. & Katsanis, E. Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity. Blood 101, 245-252 (2003).
24. Basu, S., Binder, R. J., Suto, R., Anderson, K. M. & Srivastava, P. K. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int. Immunol. 12, 1539-1546 (2000).
25. + cells in vivo. J. Immunol. 165, 6029-6035 (2000).
26. Bausinger, H. et al. Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur. J. Immunol. 32, 3708-3713 (2002).
27. Shi, Y., Evans, J. E. & Rock, K. L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425, 516-521 (2003). This paper identified uric acid as an endogenous adjuvant.
28. Lotze, M. T. & Tracey, K. J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nature Rev. Immunol. 5, 331-342 (2005).
29. Scaffidi, P., Misteli, T. & Bianchi, M. E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-195 (2002). This paper showed that HMGB1 is released from necrotic but not apoptotic cells and that it induces inflammatory responses in vivo.
30. Rovere-Querini, P. et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 5, 825-830 (2004).
31. Apetoh, L. et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature Med. 13, 1050-1059 (2007). This paper provides evidence that HMGB1 is an endogenous adjuvant that contributes to tumour immunity in chemotherapy- and radiotherapy-induced cell death.
32. Ishii, K. J. et al. Genomic DNA released by dying cells induces the maturation of APCs. J. Immunol. 167, 2602-2607 (2001).
33. Bird, A. P., Taggart, M. H., Nicholls, R. D. & Higgs, D. R. Non-methylated CpG-rich islands at the human α-globin locus: implications for evolution of the α-globin pseudogene. EMBO J. 6, 999-1004 (1987).
34. Majno, G., La Gattuta, M. & Thompson, T. E. Cellular death and necrosis: chemical, physical and morphologic changes in rat liver. Virchows Arch. Pathol. Anat. Physiol. Klin. Med. 333, 421-465 (1960). This paper provides a detailed description of inflammatory responses to necrotic tissue in vivo.
35. Chen, C. J. et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nature Med. 13, 851-856 (2007). This paper shows that the IL-1α-IL-1- receptor-MYD88 pathway has an important role in the acute neutrophilic inflammatory response to cell death, whereas Toll-like receptors have only a minor role in this response.
36. Andersson, U. et al. High mobility group 1 protein (HMG1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192, 565-570 (2000).
37. Orlova, V. V. et al. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J. 26, 1129-1139 (2007).
38. Rouhiainen, A., Tumova, S., Valmu, L., Kalkkinen, N. & Rauvala, H. Analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J. Leukocyte Biol. 81, 49-58 (2007).
39. Fairs, J. S. & McCarthy, D. J. J. Acute arthritis in man and dog after intrasynovial injection of sodium urate crystals. Lancet 280, 682-685 (1962).
40. Liu, F. T. & Rabinovich, G. A. Galectins as modulators of tumour progression. Nature Rev. Cancer 5, 29-41 (2005).
41. Nakamura, H. et al. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol. Lett. 42, 75-80 (1994).
42. Sano, H. et al. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J. Immunol. 165, 2156-2164 (2000).
43. Almkvist, J. & Karlsson, A. Galectins as inflammatory mediators. Glycoconj. J. 19, 575-581 (2004).
44. Dai, S. Y. et al. Galectin-9 induces maturation of human monocyte-derived dendritic cells. J. Immunol. 175, 2974-2981 (2005).
45. Bertini, R. et al. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J. Exp. Med. 189, 1783-1789 (1999).
46. Schenk, H., Vogt, M., Droge, W. & Schulze-Osthoff, K. Thioredoxin as a potent costimulus of cytokine expression. J. Immunol. 156, 765-771 (1996).
47. Panjwani, N. N., Popova, L. & Srivastava, P. K. Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. J. Immunol. 168, 2997-3003 (2002).
48. Asea, A. et al. HSP70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nature Med. 6, 435-442 (2000).
49. Chen, W., Syldath, U., Bellmann, K., Burkart, V. & Kolb, H. Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J. Immunol. 162, 3212-3219 (1999).
50. Wallin, R. P. et al. Heat-shock proteins as activators of the innate immune system. Trends Immunol. 23, 130-135 (2002).
51. Hofmann, M. A. et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97, 889-901 (1999).
52. Ryckman, C., Vandal, K., Rouleau, P., Talbot, M. & Tessier, P. A. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 170, 3233-3242 (2003).
53. Hefeneider, S. H. et al. Nucleosomes and DNA bind to specific cell-surface molecules on murine cells and induce cytokine production. Clin. Immunol. Immunopathol. 63, 245-251 (1992).
54. Decker, P., Singh-Jasuja, H., Haager, S., Kötter, I. & Rammensee, H. G. Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation. J. Immunol. 174, 3326-3334 (2005).
55. 2 generation, respectively. J. Clin. Invest. 85, 1150-1157 (1990).
56. Poelstra, K., Heynen, E. R., Baller, J. F., Hardonk, M. J. & Bakker, W. W. Modulation of anti-Thy1 nephritis in the rat by adenine nucleotides. Evidence for an antiinflammatory role for nucleotidases. Lab. Invest. 66, 555-563 (1992).
57. Zanetti, M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukocyte Biol. 75, 39-48 (2004).
58. Yang, D. et al. LL-37, the neutrophil-granule- and epithelial-cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192, 1069-1074 (2000).
59. Yang, D. et al. β-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286, 525-528 (1999).
60. Carp, H. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J. Exp. Med. 155, 264-275 (1982).
61. Zhang, M. et al. Identification of the target self-antigens in reperfusion injury. J. Exp. Med. 203, 141-152 (2006). This paper shows that natural IgM antibodies bind myosin released from necrotic cells in ischaemia-reperfusion injury and stimulate inflammation by activating complement.
62. Williams, J. P. et al. Intestinal reperfusion injury is mediated by IgM and complement. J. Appl. Physiol. 86, 938-942 (1999).
63. Weiser, M. R. et al. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183, 2343-2348 (1996).
64. Zhang, M. et al. The role of natural IgM in myocardial ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 41, 62-67 (2006).
65. Zhang, M. et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc. Natl Acad. Sci. USA 101, 3886-3891 (2004).
66. Hill, J. H. & Ward, P. A. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J. Exp. Med. 133, 885-900 (1971).
67. Pinckard, R. N. et al. Antibody-independent activation of human C1 after interaction with heart subcellular membranes. J. Immunol. 110, 1376-1382 (1973).
68. Pfister, R. R., Haddox, J. L. & Sommers, C. I. Injection of chemoattractants into normal cornea: a model of inflammation after alkali injury. Invest. Ophthalmol. Vis. Sci. 39, 1744-1750 (1998).
69. Weathington, N. M. et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nature Med. 12, 317-323 (2006).
70. Smiley, S. T., King, J. A. & Hancock, W. W. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J. Immunol. 167, 2887-2894 (2001).
71. Taylor, K. R. et al. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279, 17079-17084 (2004).
72. Wrenshall, L. E., Cerra, F. B., Carlson, A., Bach, F. H. & Platt, J. L. Regulation of murine splenocyte responses by heparan sulfate. J. Immunol. 147, 455-459 (1991).
73. Kaplan, A. P. et al. The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation. Adv. Immunol. 66, 225-272 (1997).
74. Tsan, M. F. & Gao, B. Endogenous ligands of Toll-like receptors. J. Leukocyte Biol. 76, 514-519 (2004).
75. Bianchi, M. E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukocyte Biol. 81, 1-5 (2006).
76. Park, J. S. et al. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279, 7370-7377 (2004).
77. Liu-Bryan, R., Scott, P., Sydlaske, A., Rose, D. M. & Terkeltaub, R. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 52, 2936-2946 (2005).
78. Ohashi, K., Burkart, V., Flohe, S. & Kolb, H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J. Immunol. 164, 558-561 (2000).
79. Vabulas, R. M. et al. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J. Biol. Chem. 277, 20847-20853 (2002).
80. Biragyn, A. et al. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 298, 1025-1029 (2002).
81. Jiang, D. et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nature Med. 11, 1173-1179 (2005).
82. Johnson, G. B., Brunn, G. J., Kodaira, Y. & Platt, J. L. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 168, 5233-5239 (2002).
83. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241 (2006).
84. Chen, C. J. et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J. Clin. Invest. 116, 2262-2271 (2006).
85. Warger, T. et al. Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses. J. Biol. Chem. 281, 22545-22553 (2006).
86. Kokkola, R. et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 61, 1-9 (2005).
87. Dumitriu, I. E. et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J. Immunol. 174, 7506-7515 (2005).
88. Basu, S., Binder, R. J., Ramalingam, T. & Srivastava, P. K. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14, 303-313 (2001).
89. Delneste, Y. et al. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17, 353-362 (2002).
90. Fan, S. T. & Edgington, T. S. Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor-α responses of monocytes. J. Immunol. 150, 2972-2980 (1993).
91. Kobayashi, H. & Terao, T. Hyaluronic acid-specific regulation of cytokines by human uterine fibroblasts. Am. J. Physiol. 273, C1151-C1159 (1997).
92. Gregersen, P. K. & Behrens, T. W. Genetics of autoimmune diseases - disorders of immune homeostasis. Nature Rev. Genet. 7, 917-928 (2006).
93. Romson, J. L. et al. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67, 1016-1023 (1983).
94. Hall, T. S. et al. The role of leukocyte depletion in reducing injury to the lung after hypothermic ischemia. Curr. Surg. 44, 137-139 (1987).
95. Sadasivan, K. K., Carden, D. L., Moore, M. B. & Korthuis, R. J. Neutrophil mediated microvascular injury in acute, experimental compartment syndrome. Clin. Orthop. Relat. Res. 339, 206-215 (1997).
96. Liu, Z. X., Han, D., Gunawan, B. & Kaplowitz, N. Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology 43, 1220-1230 (2006).
97. Ghio, A. J., Kennedy, T. P., Hatch, G. E. & Tepper, J. S. Reduction of neutrophil influx diminishes lung injury and mortality following phosgene inhalation. J. Appl. Physiol. 71, 657-665 (1991).
98. Dovi, J. V., He, L. K. & DiPietro, L. A. Accelerated wound closure in neutrophil-depleted mice. J. Leukocyte Biol. 73, 448-455 (2003).
99. Faouzi, S. et al. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-κB-independent, caspase-3-dependent pathway. J. Biol. Chem. 276, 49077-49082 (2001).
100. Huynh, M. L., Fadok, V. A. & Henson, P. M. Phosphatidylserine- dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J. Clin. Invest. 109, 41-50 (2002).
101. Ronnefarth, V. M. et al. TLR2/TLR4-independent neutrophil activation and recruitment upon endocytosis of nucleosomes reveals a new pathway of innate immunity in systemic lupus erythematosus. J. Immunol. 177, 7740-7749 (2006).
102. Boule, M. W. et al. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199, 1631-1640 (2004).
103. Tsan, M. F. & Gao, B. Cytokine function of heat shock proteins. Am. J. Physiol. Cell. Physiol. 286, C739-C744 (2004).
104. Schmitt, E., Gehrmann, M., Brunet, M., Multhoff, G. & Garrido, C. Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J. Leukocyte Biol. 81, 15-27 (2007).
105. Melcher, A. et al. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nature Med. 4, 581-587 (1998). This paper shows that the expression of heat-shock proteins in tumour cells is increased by necrotic but not apoptotic cell death and is related to immunogenicity in vivo.
106. Bours, M. J., Swennen, E. L., Di Virgilio, F., Cronstein, B. N. & Dagnelie, P. C. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112, 358-404 (2006).
107. Fredholm, B. B. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 14, 1315-1323 (2007).
108. Idzko, M. et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nature Med. 13, 913-919 (2007).
109. H1 responses. J. Immunol. 166, 1611-1617 (2001).
110. Yang, D., Biragyn, A., Hoover, D. M., Lubkowski, J. & Oppenheim, J. J. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol. 22, 181-215 (2004).
111. Davidson, D. J. et al. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 172, 1146-1156 (2004).
112. Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564-569 (2007).
113. Lillard, J. W. Jr, Boyaka, P. N., Chertov, O., Oppenheim, J. J. & McGhee, J. R. Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proc. Natl Acad. Sci. USA 96, 651-656 (1999).
114. Gawlowski, D. M., Benoit, J. N. & Granger, H. J. Microvascular pressure and albumin extravasation after leukocyte activation in hamster cheek pouch. Am. J. Physiol. 264, H541-H546 (1993).
115. Sozzani, S. et al. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol. 155, 3292-3295 (1995).
116. Mummert, D. I., Takashima, A., Ellinger, L. & Mummert, M. E. Involvement of hyaluronan in epidermal Langerhans cell maturation and migration in vivo. J. Dermatol. Sci. 33, 91-97 (2003). This paper shows that the interaction of hyaluronic acid with Langerhans cells contributes to the development of contact hypersensitivity in vivo by using a specific inhibitory peptide.
117. Scheibner, K. A. et al. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177, 1272-1281 (2006).
118. Termeer, C. C. et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J. Immunol. 165, 1863-1870 (2000).
119. Tobiasova-Czetoova, Z. et al. Effects of human plasma proteins on maturation of monocyte-derived dendritic cells. Immunol. Lett. 100, 113-119 (2005).
120. Mahnke, K., Bhardwaj, R. S., Luger, T. A., Schwarz, T. & Grabbe, S. Interaction of murine dendritic cells with collagen up-regulates allostimulatory capacity, surface expression of heat stable antigen, and release of cytokines. J. Leukocyte Biol. 60, 465-472 (1996).
121. Brand, U. et al. Influence of extracellular matrix proteins on the development of cultured human dendritic cells. Eur. J. Immunol. 28, 1673-1680 (1998).
122. Houghton, A. M. et al. Elastin fragments drive disease progression in a murine model of emphysema. J. Clin. Invest. 116, 753-759 (2006).
123. Adair-Kirk, T. L. et al. A site on laminin α5, AQARSAASKVKVSMKF, induces inflammatory cell production of matrix metalloproteinase-9 and chemotaxis. J. Immunol. 171, 398-406 (2003).